BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15553921)

  • 1. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
    Sriram D; Yogeeswari P; Yelamanchili Priya D
    Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydro-2H-1,3,5-thiadiazine-5-(4-pyridylcarboxamide)-2-thione derivatives as prodrugs for isoniazid; synthesis, investigations and in vitro antituberculous activity.
    Aboul-Fadl T; Hassanin K
    Pharmazie; 1999 Apr; 54(4):244-7. PubMed ID: 10234734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on the Mechanism of Action of INH-C
    Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
    Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
    Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
    Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
    Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
    Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
    Rodrigues-Junior VS; Dos Santos Junior A; Dos Santos AJ; Schneider CZ; Calixto JB; Sousa EH; de França Lopes LG; Souto AA; Basso LA; Santos DS; Campos MM
    Int J Antimicrob Agents; 2012 Aug; 40(2):182-5. PubMed ID: 22748570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid.
    Hearn MJ; Cynamon MH; Chen MF; Coppins R; Davis J; Joo-On Kang H; Noble A; Tu-Sekine B; Terrot MS; Trombino D; Thai M; Webster ER; Wilson R
    Eur J Med Chem; 2009 Oct; 44(10):4169-78. PubMed ID: 19524330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
    Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D; Manjashetty TH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1152-4. PubMed ID: 19131245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
    Ali MA; Yar MS; Kumar M; Pandian GS
    Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recall of isoniazid used for antimicrobial susceptibility testing for tuberculosis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(34):780-2. PubMed ID: 10987246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
    Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
    Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
    J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.